Swedish Orphan Biovitrum
411.00 SEK
+1.23 %
Less than 1K followers
SOBI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Swedish Orphan Biovitrum
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6,894.0 | 7,435.0 | 26,027.0 | 6,465.0 | 6,175.0 | 7,776.0 | 7,822.0 | 28,238.0 |
| EBITDA | 2,962.0 | 2,638.0 | 9,304.0 | 2,296.0 | 1,899.0 | 3,656.0 | 3,112.0 | 10,963.0 |
| EBIT | 2,038.0 | 1,662.0 | 5,625.0 | 1,358.0 | 1,010.0 | -3,858.0 | 2,357.0 | 867.0 |
| EBIT-% | 29.6 % | 22.4 % | 21.6 % | 21.0 % | 16.4 % | -49.6 % | 30.1 % | 3.1 % |
| Profit before taxes | 1,712.0 | 1,438.0 | 4,407.0 | 1,096.0 | 794.0 | -4,027.0 | 2,171.0 | 34.0 |
| Net income | 1,464.0 | 1,391.0 | 3,879.0 | 875.0 | 634.0 | -2,895.0 | 1,862.0 | 476.0 |